Oric Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORIC and other ETFs, options, and stocks.About ORIC
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology.
CEOJacob M. Chacko
CEOJacob M. Chacko
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2014
Founded2014
Employees115
Employees115
ORIC Key Statistics
Market cap832.68M
Market cap832.68M
Price-Earnings ratio-4.70
Price-Earnings ratio-4.70
Dividend yield—
Dividend yield—
Average volume1.06M
Average volume1.06M
High today$8.92
High today$8.92
Low today$8.15
Low today$8.15
Open price$8.51
Open price$8.51
Volume1.19M
Volume1.19M
52 Week high$14.93
52 Week high$14.93
52 Week low$3.90
52 Week low$3.90
Stock Snapshot
Oric Pharmaceuticals(ORIC) stock is priced at $8.55, giving the company a market capitalization of 832.68M. It carries a P/E multiple of -4.70.
As of 2026-01-07, Oric Pharmaceuticals(ORIC) stock has fluctuated between $8.15 and $8.92. The current price stands at $8.55, placing the stock +4.9% above today's low and -4.1% off the high.
The Oric Pharmaceuticals(ORIC)'s current trading volume is 1.19M, compared to an average daily volume of 1.06M.
During the past year, Oric Pharmaceuticals(ORIC) stock moved between $3.90 at its lowest and $14.93 at its peak.
During the past year, Oric Pharmaceuticals(ORIC) stock moved between $3.90 at its lowest and $14.93 at its peak.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
People also own
Based on the portfolios of people who own ORIC. This list is generated using Robinhood data, and it’s not a recommendation.